IQQY.XETRA iShares MSCI Europe UCITS Dist
- Total assets
- 10.8B
- Expense ratio
- 0.12%
- Dividend yield
- 2.74%
- 1-year return
- +15.40%
- Holdings
- 383
- Since
- 2007
Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.
What does IQQY.XETRA invest in?
Tracks Morningstar DM Eur TME NR EUR- Mostly Non-US stocks (92.4%)
- Largest sector: Financial Services (23.4%)
- Largest region: Europe Developed (71.8%)
- Top 3 holdings: 9.2% of the fund
Asset allocation
- Non-US stocks 92.4%
- US stocks 2.1%
- Cash 0.6%
- Other 0.2%
Top holdings
- ASML Holding N.V. 4.45%
- Roche Holding AG 2.53%
- Novartis AG 2.19%
- Shell plc 2.14%
- AstraZeneca PLC 2.10%
iShares MSCI Europe UCITS Dist performance
Sharpe ratio 1.37- This year
- +11.69%
- 1 year
- +15.40%
- 3 years
- +15.71%
- 5 years
- +9.21%
Volatility 12.1% over 1 year and 9.9% over 3 years. Calm: prices usually move little.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
IQQY.XETRA price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About iShares MSCI Europe UCITS Dist
The investment objective of this Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the MSCI Europe Index. In order to achieve its investment objective, the investment policy of this Fund is to invest in a portfolio of equity securities that so far as possible and practicable consists of the component securities of the MSCI Europe Index, this Fund"s Benchmark Index.
Full fund profileiShares MSCI Europe UCITS Dist top holdings
22.1% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| ASML Holding N.V. ASML.AS | Technology | Netherlands | 4.45% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 2.53% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 2.19% |
| Shell plc SHEL.LSE | Energy | United Kingdom | 2.14% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 2.10% |
| HSBC Holdings PLC HSBA.LSE | Financial Services | United Kingdom | 2.03% |
| Nestle S.A. NESN.SW | Consumer Defensive | Switzerland | 2.01% |
| SAP SE SAP.XETRA | Technology | Germany | 1.78% |
| Siemens Aktiengesellschaft SIE.XETRA | Industrials | Germany | 1.57% |
| Allianz SE VNA O.N. ALV.XETRA | Financial Services | Germany | 1.31% |
The 10 largest of 383 holdings.
IQQY.XETRA sector exposure
- Financial Services23.4%
- Industrials18.1%
- Healthcare14.4%
- Consumer Defensive9.2%
- Technology9.0%
- Consumer Cyclicals6.2%
- Energy5.8%
- Basic Materials5.4%
- Utilities4.7%
- Communication Services3.4%
- Real Estate0.7%
Share of the stocks in the fund.
IQQY.XETRA regional exposure
- Europe Developed71.8%
- United Kingdom22.8%
- North America2.1%
- Asia Developed0.4%
- Latin America0.1%
Share of the stocks in the fund.
Company size
Average market cap 77.0B- Mega cap54.5%
- Big cap36.0%
- Medium cap10.1%
- Small cap0.1%
iShares MSCI Europe UCITS Dist fund profile
- Fund name
- iShares MSCI Europe UCITS Dist
- Ticker
- IQQY.XETRA
- Exchange
- XETRA Stock Exchange
- Fund website
- ishares.com
- Index tracked
- Morningstar DM Eur TME NR EUR
- Category
- Europe Equity
- Domicile
- Ireland
- Inception date
- Jul 6, 2007
- Trading currency
- EUR
- Expense ratio
- 0.12%
- Dividends paid
- Quarterly
- Annual turnover
- 0.1%
About iShares MSCI Europe UCITS Dist
The investment objective of this Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the MSCI Europe Index. In order to achieve its investment objective, the investment policy of this Fund is to invest in a portfolio of equity securities that so far as possible and practicable consists of the component securities of the MSCI Europe Index, this Fund"s Benchmark Index.